Wednesday, 23 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

GluBio Pharma Raises USD 22M in Series A+ Round to Advance TPD Pipeline

February 17, 2025
CompanyDeals

Ribo Life Science Raises USD 40M in Series E1 Round for siRNA Drug Development

February 17, 2025
CompanyDeals

BridGene Biosciences Completes USD 38.5M Series B Round with China Funds

February 17, 2025
CompanyDeals

Basecare Medical Sells 35% Stake in Cellpro Biotech for USD 9.5M

February 17, 2025
CompanyDrug

Sanjin Pharma’s Subsidiary Gets FDA Nod for BC007 Cancer Drug Trial

February 17, 2025
CompanyDeals

Pica Partners with BrainCo to Launch ADHD Product in China

February 17, 2025
HospitalPolicy / Regulatory

NHC Designates National Mental Illness Medical Centers in Beijing and Shanghai

February 18, 2025
CompanyDrug

Innovent and Laekna Dose First Patient in Afuresertib and Tyvyt Study for PD-1 Resistant Tumors

February 18, 2025
CompanyDrug

Dongcheng Pharmaceutical Gets NMPA Green Light for PSMA PET Imaging Drug

February 18, 2025
CompanyDrug

CanSino Biologics Launches Menhycia Meningococcal Vaccine in Six Provinces

February 18, 2025
CompanyDrug

Mabwell Bioscience Gets FDA Approval for Nectin-4 ADC 9MW2821 in Solid Tumors

February 18, 2025
CompanyDrug

LaNova Medicines Gets FDA Green Light for LM-305 Myeloma Study

February 18, 2025
1 2 … 20 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up